Juliet C. Gray
机构:Southampton Children's Hospital, Cancer Research UK Clinical Trials Unit, University of Southampton · ORCID:0000-0002-5652-4722
发表论文 216 篇 · 总被引 1769 次 · h-index 23
代表论文
- EZH2 inhibition enhances NK cell-mediated cytotoxicity and potentiates anti-GD2 immunotherapy in neuroblastoma (2026 · Research Square)
- The glycogen synthase kinase-3β inhibitor 9-ING-41 enhances chemoimmunotherapy efficacy in preclinical models of high-risk neuroblastoma (2026 · Research Square)
- Supplementary Table 8 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States (2026)
- Supplementary Table 7 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States (2026)
- Supplementary Table 6 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States (2026)
- Supplementary Table 4 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States (2026)